◂ Announcements

Jul 4, 2018NEW FACILITYPouso Alegre, Minas Gerais, Brazil

Biolab plans R$ 450 million plant in Pouso Alegre, Brazil

Biolab is planning to open a new plant in Pouso Alegre (MG) with an investment of R$ 450 million. The plant is part of the company's expansion into generics and CNS.

Value

$117.0M (450.0M BRL)

Status

Announced

Productsgeneric drugs

CompaniesBiolab

“Biolab has just entered a new market, generic drugs, with a turnover forecast of more than R$ 150 million in 2019.”biolabeco.com.br

1 source
biolabeco.com.brBiolab enters generics and evaluates purchase in Canada - Biolab & CoJul 4, 2018

Summarized from public sources; check the original articles before acting on it.

More from Biolab

profile ▸

Jun 30, 2021NEW FACILITYWestlake, Louisiana, United States$170.0M82 jobsops 2022
BioLab to build $170 million chlorine plant in Westlake, Louisiana
Biolab KIK Consumer Products investor opportunitylouisiana.gov poolspamarketing.com
Jan 29, 2019ACQUISITIONUnited States
KIK Custom Products acquires NC Brands
Biolab acquirer KIK Custom Products acquirer aquamagazine.com poolpromag.com sparetailer.com
Jul 4, 2018ACQUISITIONRio de Janeiro, Brazil$13.0M
Biolab acquires Actavis Brasil from Teva
Biolab acquirer Actavis Brasil target biolabeco.com.br

Loading…

Biolab plans R$ 450 million plant in Pouso Alegre, Brazil · Endata